Kou Mark Hwang

Title: Kou Mark Hwang: Innovator in Herbal Medicine and Alzheimer's Treatment

Introduction

Kou Mark Hwang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the fields of herbal medicine and drug delivery systems. With a total of 2 patents, Hwang's work focuses on innovative solutions for serious health issues.

Latest Patents

Hwang's latest patents include ST 188L, a formulation designed for the prevention and treatment of cancers and infections. This invention provides Chinese herbal compositions that have shown effectiveness in stimulating the activity of natural killer (NK) cells and lymphokine-activated killer (LAK) cells. The results indicate that ST 188L can enhance the immune system of cancer patients, keeping them cancer-free for over ten years. Another significant patent is the transdermal rate-controlled delivery of Huperzine A for the treatment of Alzheimer's disease. This novel drug delivery system allows for the convenient administration of Huperzine A through a controlled-release skin patch, designed for once-a-week application, improving the efficacy of treatment for Alzheimer's patients.

Career Highlights

Kou Mark Hwang is associated with Sagittarius Life Science Corporation, where he continues to develop innovative health solutions. His work has garnered attention for its potential impact on patient care and treatment outcomes.

Collaborations

Hwang collaborates with talented individuals such as Suying Liu and Yi Ming Tsai, contributing to a dynamic research environment focused on advancing medical science.

Conclusion

Kou Mark Hwang's contributions to herbal medicine and drug delivery systems highlight his commitment to improving health outcomes. His innovative patents reflect a deep understanding of both traditional and modern medical practices.